Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Ductus Arteriosus, Patent
- Comparision Between Paracetamol and Ibuprofen in Closure of Patent Ductus Arteriosus
- Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants
- Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
- Ibuprofen Treatment of Hemodynamically Significant Patent Ductus Arteriosus (hsPDA) in Preterm Infants
- Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT
- PAIR (Paracetamol and Ibuprofen Research) Pilot Trial
- Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
- Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
- Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis
- Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus
- Addition of Acetaminophen in Standard PDA Management
- Indomethacin PK-PD in Extremely Preterm Neonates
- Early Treatment Versus Expectant Management of PDA in Preterm Infants
- Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
- Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus
- Alternative Paracetamol Treatments for the Neonate With a hsPDA
- Acetaminophen vs Indomethacin in Treating hsPDA
- Paracetamol Versus Ibuprofen for PDA Closure
- Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus
- Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates
- IV Acetaminophen and Patent Ductus Arteriosus
- Early Treatment Versus Expectative Management of PDA in Preterm Infants
- Paracetamol Treatment of the Borderline Significant PDA
- Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
- The Best Treatment Strategy: Surgical vs Pharmacological to Close the Ductus Arteriosus Persistent in Preterm Infants
- Paracetamol in Patent Ductus Arteriosus
- No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
- Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.
- Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants
- Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
- The Preterm Infants' Paracetamol Study
- Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants
- Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)
- Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
- Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
- Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial
- Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
- Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
- Oral Ibuprofen Prophylaxis for Patent Ductus Arterioses in Very Extremely Low Birth Weight Infants
- Paracetamol and Patent Ductus Arteriosus (PDA)
- Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants
- High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant
- Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
- Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
- Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
- Timing of PDA Closure and Respiratory Outcome in Premature Infants
- Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
- An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
- Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
- Treating the Resistant Patent Ductus Arteriosus (PDA)
- Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
- Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies
- Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
- New Management Strategy of PDA for VLBW Preterm Infants
- Ibuprofen and Renal Function in Premature Infants
- Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
- Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)
- Management of Patent Ductus in Premature Infants